* Disse uønskede hændelser var almindelige (≥1/ 100 til < 1/ 10) hos patienter med kronisk hepatitis B, der bliver behandlet med Pegasys monoterapi
*These adverse reactions were common (≥ 1/ 100 to < 1/ 10) in CHB patients treated with Pegasys monotherapy